Arcarios BV
http://www.arcarios.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Arcarios BV
BMS Scoops Cormorant In $520M Immuno-Oncology Deal
Bristol-Myers Squibb Co. has bolstered its immuno-oncology ambitions by acquiring IL-8 focused Cormorant Pharmaceuticals AB, the 4-year old Swedish biotech. Cormorant’s shareholders are getting $95M up front with the promise of a further $425M if milestones are achieved.
Genmab Fails To Convince CHMP Of Case For Maintenance Arzerra
The anti-CD20 monoclonal antibody Arzerra (ofatumumab) has not been recommended for the maintenance therapy of relapsed chronic lymphocytic leukemia (CLL), an expanded indication, by the Committee for Medicinal Products for Human Use (CHMP).
Sequoia Capital Invests In Saint Lucia Consulting For U.S.-Linked Cancer Treatment Program
As an exclusive partner of U.S. Partners HealthCare International (PHI), Saint Lucia Consulting has received investment funds from Sequoia Capital and will provide cancer evaluation services (CES) for Chinese patients who are seeking medical treatment in U.S.
Recent Financings of Private Companies (11/2010)
Start-Up's monthly comprehensive review of emerging life science companies that have received venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation and reagent sectors.
Company Information
- Industry
- Pharmaceuticals
-
Biotechnology
- Large Molecule
-
Drug Discovery Tools
- Genomics-Proteomics
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice